Trial intelligence / Profile preview

UFT outcome research in NSAS-BC01 and CUBC breast cancer cohorts

jRCT1080223266Completed

Sponsor
Taiho Pharmaceutical Co., Ltd.
Start
Jul 2016
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of tegafur + uracil in breast cancer, sponsored by Taiho Pharmaceutical Co., Ltd. Started Jul 2016; status: completed.

02

Drugs

tegafur + uracil
03

Conditions

breast cancer

Beyond the preview

Go deeper on jRCT1080223266.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080223266.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call